Provided by Tiger Fintech (Singapore) Pte. Ltd.

Lantheus

79.19
+0.20000.25%
Post-market: 79.190.00000.00%16:48 EDT
Volume:1.54M
Turnover:121.62M
Market Cap:5.48B
PE:22.43
High:80.30
Open:79.36
Low:78.11
Close:78.99
Loading ...

Lantheus Appoints Phuong Khanh (P.k.) Morrow, M.d., as New Board Member

THOMSON REUTERS
·
30 Jan

Lantheus Appoints Phuong Khanh (P.K.) Morrow, M.D., as New Board Member

GlobeNewswire
·
30 Jan

Lantheus’s Strategic Acquisition of Evergreen Theragnostics Strengthens Radiopharmaceutical Leadership and Growth Prospects

TIPRANKS
·
30 Jan

LNTH: Evergreen Acquisition Promotes Future Innovation

Zacks Small Cap Research
·
30 Jan

Strategic Acquisitions and Market Growth Propel Lantheus to a Buy Rating

TIPRANKS
·
29 Jan

TD Cowen Sticks to Its Buy Rating for Lantheus (LNTH)

TIPRANKS
·
29 Jan

Truist Financial Keeps Their Buy Rating on Lantheus (LNTH)

TIPRANKS
·
29 Jan

Why Lantheus Holdings Stock Got Thrashed on Tuesday

Motley Fool
·
29 Jan

BUZZ-Lantheus falls on up to $1 billion acquisition

Reuters
·
29 Jan

Strategic Expansions and Acquisitions Position Lantheus for Growth in Oncology and Radiopharma Sectors

TIPRANKS
·
29 Jan

Lantheus Holdings’ Strategic Advancements and Acquisitions Reinforce Buy Rating

TIPRANKS
·
29 Jan

Lantheus To Buy Evergreen Theragnostics For Over $1 Billion To Bolster Its Cancer Radiopharmaceutical Portfolio

Benzinga
·
28 Jan

Lantheus Holdings to Acquire Evergreen Theragnostics in All-Cash Transaction

MT Newswires Live
·
28 Jan

Lantheus to Acquire Evergreen Theragnostics for $250 Million

TIPRANKS
·
28 Jan

Lantheus to Acquire Evergreen Theragnostics for Upfront Payment of $250 Million to Drive Strategic Evolution Into Fully Integrated Radiopharmaceutical Leader

THOMSON REUTERS
·
28 Jan

Lantheus Holdings Inc - Reaffirms Full-Year and Q4 2024 Financial Guidance

THOMSON REUTERS
·
28 Jan

Lantheus acquires Evergreen Theragnostics for $250M upfront payment

TIPRANKS
·
28 Jan

Lantheus Reaffirms FY 2024 Revenue Of $1.51B-$1.52B, And Adjusted EPS Of $6.65-$6.70 Compared To Consensus Of $1.52B And $6.74, Respectively

Benzinga
·
28 Jan

Lantheus Holdings Inc - Reaffirms Full-Year and Q4, 2024 Financial Guidance

THOMSON REUTERS
·
28 Jan

Lantheus to Acquire Evergreen Theragnostics for Upfront Payment of $250 Million to Drive Strategic Evolution Into Fully Integrated Radiopharmaceutical Leader

THOMSON REUTERS
·
28 Jan